Literature DB >> 6864475

Esterase-like activity of human serum albumin II: reaction with N-trans-cinnamoylimidazoles.

N Ohta, Y Kurono, K Ikeda.   

Abstract

To elucidate the details of the esterase activity of human serum albumin, the reaction of N-trans-cinnamoylimidazoles with albumin was investigated kinetically at various pHs at 25 degrees. The reaction consisted of the acylation of albumin (probably the tyrosine-411 residue) by the substrate and the deacylation of cinnamoyl-albumin. The acylation was approximately 10--100-fold faster than the spontaneous hydrolysis of the substrate over the pH range examined. The pH profile for the deacylation rate constant indicated the participation of a group having a pKa of approximately 9.4. The deacylation was subjected to the effect of deuterium oxide. The electron-withdrawing substituent facilitated the deacylation; the Hammett rho value was 1.63. These results suggest that the deacylation proceeded via general base catalysis by this group.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6864475     DOI: 10.1002/jps.2600720416

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  5 in total

1.  The esterase-like activity of serum albumin may be due to cholinesterase contamination.

Authors:  N Chapuis; C Brühlmann; M Reist; P A Carrupt; J M Mayer; B Testa
Journal:  Pharm Res       Date:  2001-10       Impact factor: 4.200

Review 2.  Clinical significance of esterases in man.

Authors:  F M Williams
Journal:  Clin Pharmacokinet       Date:  1985 Sep-Oct       Impact factor: 6.447

3.  Esterase-like activity of serum albumin: characterization of its structural chemistry using p-nitrophenyl esters as substrates.

Authors:  Yuji Sakurai; Shen-Feng Ma; Hiroshi Watanabe; Noriyuki Yamaotsu; Shuichi Hirono; Yukihisa Kurono; Ulrich Kragh-Hansen; Masaki Otagiri
Journal:  Pharm Res       Date:  2004-02       Impact factor: 4.200

4.  Ligand binding to the FA3-FA4 cleft inhibits the esterase-like activity of human serum albumin.

Authors:  Paolo Ascenzi; Loris Leboffe; Alessandra di Masi; Viviana Trezza; Gabriella Fanali; Magda Gioia; Massimo Coletta; Mauro Fasano
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

5.  Prediction of Human Pharmacokinetic Profiles of the Antituberculosis Drug Delamanid from Nonclinical Data: Potential Therapeutic Value against Extrapulmonary Tuberculosis.

Authors:  Masakazu Shibata; Masatoshi Masuda; Katsunori Sasahara; Hiroyuki Sasabe; Tomohiro Sasaki; Seongryul Kim; Kenji Takeuchi; Ken Umehara; Eiji Kashiyama
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.